Home Antitrust Chronicle 2012 Summer 2012, Volume 7, Number 2

Summer 2012, Volume 7, Number 2

chronicle

European Commission Enforcement in the Pharmaceutical Sector: Less Than Expected? The...

Sean-Paul Brankin, Jul 27, 2012 On July 6, 2011, the European Commission closed the case file in itsBoehringer/Almirall investigation. It did so without a formal...

Why a Reduction in Health Care Costs Per Se May be...

Rosa Abrantes-Metz, Jul 27, 2012 There is nearly universal agreement that a restructuring of the health care system is required, particularly with regard to the...

Pharmaceutical Patents, Settlements, Reverse Payments, and Exclusion: Update

John Bigelow, Jul 27, 2012 In the June issue of this Chronicle my fellow contributors and I described a trend in appellate court decisions involving...

From Astra-Zeneca to Pfizer: When Protection of Originators Patents Ceases to...

Stefano Grassani, Jul 27, 2012 On Jan. 11, 2012, the Italian Antitrust Authority ("IAA") found Pfizer Inc. and its Swedish and Italian subsidiaries guilty of...

JUL-12(2)

The final issue in our health series brings in a global perspective. Four of our authors take a look at the EU approach to...

News

Antitrust Mix by CPI